Plain-English translation of NCT05538130 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Melanoma research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This study is testing a new cancer medication called , given together with another medication called , in people with advanced cancers that have a specific genetic mutation (BRAF V600). Researchers want to learn whether this combination is safe and how well it works against different types of cancer. You would take both medications as tablets at home, twice a day.
Many advanced cancers have a specific genetic change that doctors can now target with new treatments. This trial exists to see if combining two medications might work better than using them alone, and to understand what side effects to expect.
You likely qualify if…
You likely don't qualify if…
You would take two medications by mouth at home, twice daily, as tablets. You would continue treatment until your cancer stops responding, you experience unacceptable side effects, or after 2 years (though some participants may continue longer). Throughout the study, your doctor will monitor your health with blood tests, imaging scans, and office visits to track how you are doing and watch for any side effects.
AI-generated summary from trial data · Jul 20, 2026 · Not medical advice
United States